Research News and Research

RSS

New multilingual chronic obstructive pulmonary disease website

The European Respiratory Society has launched a new multilingual website specifically targeted at patients with chronic bronchitis, emphysema or other “chronic obstructive pulmonary disease” (COPD), group of conditions in which the patient has an expiratory airflow obstruction that causes air to become trapped in the lung and limit the ability to exhale.

5 Sep 2004

Nicotine patches and gum less effective for women than men

Research at Texas A&M University reveals that one of the most widely used forms of treatment - nicotine replacement therapy (NRT), or nicotine chewing gum and 'the patch' - may be less effective for women than men.

5 Sep 2004

Conference – Childhood leukaemia: incidence, causal mechanisms and prevention

The advances in treating childhood leukaemia over the last forty years have been one of cancer’s outstanding success stories – but the fall in mortality has diverted attention from a rise in incidence, a London conference will hear today (Monday 6 September).

5 Sep 2004

Research may significant consequences in leading drug researchers to develop new and more effective means to block influenza and other viruses

Combating viruses is often a frustrating business. Find a way to destroy them - and before you know it, they’ve found a way to defend themselves and neutralize the anti-viral treatment.

5 Sep 2004

Air conditioning coil reduces over all sickness by 20%

Air conditioning coil reduces over all sickness by 20%, reduces respiratory symptoms by 40% and has resulted in a 99% reduction of microbial and endotoxin concentrations on irradiated surfaces within the ventilation system.

5 Sep 2004

Yellow glasses save vision

Blue light destroys certain structural elements in the eye, as was revealed by the Russian research team. The mechanism of this effect was studied, and protective measures were offered.

5 Sep 2004

Widely used antimalarial drug exhibits antiviral activity against the SARS

Virologists from the Katholieke Universiteit Leuven in Belgium report that chloroquine, a widely used antimalarial drug, exhibits antiviral activity against the SARS coronavirus. Chloroquine is an inexpensive and safe drug available worldwide.

5 Sep 2004

Researchers unravel genetic makeup of ticks to tackle disease

Ticks as small as a freckle can transmit a number of illnesses for which there is no vaccine and, in some cases, no cure. These creatures even could become bioterrorism weapons.

4 Sep 2004

Britons are taller, straighter and larger than ever

Size UK measured the body shapes of around 1,500 Mancunian men and women in October 2001 among 10,000 measured nationwide under the survey backed by the department of trade and industry and a consortium or retailers including Marks & Spencer, GUS, N Brown and Redcats.

2 Sep 2004

Three key responses behind food neophobia, the rejection of new foods in both adults and children

Yuk! That short expressive word, the trademark of the fussy eater, is dreaded by thousands of parents.

2 Sep 2004

Smoking, high blood pressure and high cholesterol have taken a substantial toll on the American wallet

When these cardiovascular risk factors led to a fatal heart attack or stroke in people who had not had a previous heart attack or stroke, it cost more than $13 billion in hospitalization and lost wages annually.

2 Sep 2004

Evidence that MRSA control policies in hospitals are poor

The researchers stress that, although better studies are urgently needed, isolation measures should continue until further research establishes otherwise.

2 Sep 2004

Many low-income countries are unlikely to reach the health targets set for 2015

Many low-income countries are unlikely to reach the Millennium Development Goal (MDG) health targets set for 2015; the main reasons for this are fragile health systems and insufficient investments in understanding how to strengthen them, suggest authors of a Public Health article in this week’s issue of THE LANCET.

2 Sep 2004

World needs to commit more resources to treat people infected with HIV

Leaders of the International AIDS Vaccine Initiative (IAVI) have stressed that as the world commits more resources to treat people infected with HIV, it must also intensify efforts to develop a vaccine to prevent new infections and stop the continuing spread of the virus.

2 Sep 2004

New ways of looking at treatment for lung diseases such as pulmonary fibrosis

A research team at Yale University has found that blocking a kind of cell death called apoptosis in fibrotic diseases of the lung, also blocks the fibrosis, opening new ways of looking at treatment for lung diseases such as pulmonary fibrosis.

2 Sep 2004

Domestic violence costs the UK £3 billion a year

Time off work due to injuries caused by domestic violence is costing employers and workers nearly £3 billion a year according to figures released today by Deputy Women's Minister Jacqui Smith.

2 Sep 2004

Study finds psychological distress varies between ethnic groups

The largest UK study of psychological distress among ethnic minority adolescents has found higher rates of depressive symptoms among non-UK White pupils compared with White UK pupils.

2 Sep 2004

Research suggests that victimisation in childhood increases risk of psychotic disorders, such as schizophrenia or manic depression

People with psychosis report a marked excess of victimising experiences, many of which occurred during childhood, according to a new study.

2 Sep 2004

Rural doctors less likely to diagnose depression in men than in women

It is known that doctors are generally less likely to diagnose depression in men than in women. Little research has been undertaken to explore the reasons for this in rural settings, or to compare GPs' and male patients' assessments of perceived depression.

2 Sep 2004

University of Nottingham research developments could mean new drugs will reach cancer patients more quickly

A £3 million grant and the establishment of a specialized business unit that will help new treatments reach cancer patients more quickly, have underlined The University of Nottingham’s place at the forefront of cancer drug development.

2 Sep 2004